SER — Serina Therapeutics, Inc.

US Healthcare Pharma & biotech equity mkt cap 72.9M
2.87 +8.30% today
USD · as of 2026-08-21

Price · 2024-08-26 → 2026-08-21

499 daily closes shown
52w low 1.28 · high 5.65

Anonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2018-11-29.

Performance

1 day+8.30%
1 week+2.50%
1 month+37.32%
3 months+52.09%
6 months+77.16%
Year to date+38.11%
1 year-44.81%
3 years-90.18%
5 years-93.31%

Technicals

RSI 1476.8
vs 50-day avg+31.60%
vs 200-day avg+21.77%
Volatility 1y137.4%
Max drawdown 1y-77.35%
Avg volume 30d52.0K
Daily bars held1,941
History from2018-11-29

Measured signals that fired on SER

datesignal measured base rate
2026-04-30Short volume far above its own normal
short
-0.76% over 21 days · t = -2.79 · n = 5,897
statistically distinguishable from its control group
2026-03-30Fair value gap, bearish
structure
-0.45% over 21 days · t = -3.29 · n = 108,591
statistically distinguishable from its control group
2026-03-19Fair value gap, bullish
structure
-0.67% over 21 days · t = -6.43 · n = 111,973
statistically distinguishable from its control group

Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →

Insider transactions (Form 4)

dateinsiderwhatshares pricevalue
2026-07-07Brannan Stephen K.
Director
Open-market purchase1.0K2.032.0K
2026-06-17Bailey Gregory
Director
Conversion6.7M2.2515.0M
2026-06-17Bailey Gregory
Director
Conversion1.8M2.254.0M
2026-06-17Venkatesan Jay
Director
Conversion224.2K2.25504.3K
2026-06-12WILSON KAREN J
Director
Open-market purchase5.0K1.778.8K
2026-06-11WILSON KAREN J
Director
Open-market purchase5.1K1.758.9K
2026-05-26LEDGER STEVEN A
Chief Executive Officer
Grant or award10.1K1.9319.5K
2026-05-22WILSON KAREN J
Director
Open-market purchase10.0K1.9319.3K
2026-05-22Venkatesan Jay
Director
Open-market purchase5891.781.0K
2026-05-21WILSON KAREN J
Director
Open-market purchase10.0K1.7717.7K

Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →

Largest institutional holders

managervalueshares
Sio Capital Management, LLC1.9M1.0M
VANGUARD CAPITAL MANAGEMENT LLC308.7K159.1K
Waverly Advisors, LLC130.9K67.5K
GEODE CAPITAL MANAGEMENT, LLC126.0K65.0K
BlackRock, Inc.113.0K58.3K
JANE STREET GROUP, LLC76.9K39.7K
VANGUARD FIDUCIARY TRUST CO38.8K20.0K
Avidian Wealth Enterprises, LLC36.5K18.8K
STATE STREET CORP24.8K12.8K
Caitong International Asset Management Co., Ltd7.7K4.0K

13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →

Latest SEC filings

formfiledperiod
S-82026-08-13on EDGAR ↗
8-K2026-08-132026-08-13on EDGAR ↗
10-Q2026-08-132026-06-30on EDGAR ↗
42026-07-232026-07-22on EDGAR ↗
32026-07-232026-07-22on EDGAR ↗
8-K2026-07-232026-07-19on EDGAR ↗
8-K2026-07-222026-07-22on EDGAR ↗
SCHEDULE 13D/A2026-07-22on EDGAR ↗

Short selling

Avg short volume, 90d42.5% of tape
Days observed61

This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →

Recent headlines

Ask the AI about SER

The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.

Open SER in the terminal → How the AI works

Everything on this page is live in the terminal.

Charts, filings, insider flow and the AI — open without an account.

Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →